VAL - バルスパ― ()

VALのニュース

   ValiRx PLC - Block Listing Application and Company Update - Vox Markets  2020/08/19 06:00:00 VOX Markets
Application has been made to the London Stock Exchange for the block listing of securities in respect of 9,034,732 ordinary shares of 0.1 pence each to be admitted to trading on AIM.. The block listing application relates to 9,034,732 ordinary shares of 0.1 pence each to be issued from time to time in order to satisfy the potential exercise of the Fundraise…
   ValiRx PLC - Holding(s) in Company - Vox Markets  2020/08/14 14:57:00 VOX Markets
RNS Number: 2357 W ValiRx PLC 14 August 2020 TR-1: S tandard form for notification of major holdings. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
   ValiRx PLC - Director/PDMR Shareholding - Vox Markets  2020/08/07 13:20:00 VOX Markets
London, UK 7 August 2020: ValiRx Plc, the clinical stage biotechnology company announces the following dealing in the ordinary shares of the Company made by a Director.. On 7 August 2020, the Company was informed that Dr Kevin Cox, Non-executive Chairman of the Company, acquired 117,000 ValiRx ordinary shares at an average price of 8.2 pence per share on 7 August…
   Valor Resources : Quarterly Cashflow Report.pdf (7) | MarketScreener  2020/08/03 07:44:29 MarketScreener
Rule 5.5 Appendix 5B Mining exploration entity or oil and gas exploration entity … | August 3, 2020
   India to play impt part in producing Covid vaccines  2020/07/30 16:22:13 Economic Times India
MUMBAI: India has a crucial role to play in the production of Covid-19 vaccines, with the largest manufacturing capacity in the world, top experts and researchers said on Thursday, while also emphasising that there should be no compromises on safety, efficacy and equitable distribution.“India’s private sector has an important role as the world’s leading manufacturer of vaccines. And as effective global vaccines emerge, India’s manufacturing capability is going to be very important,” said Anthony S Fauci, director of the National Institute of Allergy and Infectious Diseases, who oversees vaccine development in the US.Fauci was among the leading infectious disease experts and vaccine researchers who took part in the India Vaccine Symposium organised by the Indian Council of Medical Research. Adrian Hill, director of the Jenner Institute, based within the University of Oxford, which has one of the leading vaccine candidates for Covid-19, and Peter Piot, director of the London School of Hygiene & Tropical Medicine, were among the speakers.NIAID and India’s Department of Biotechnology tied up in 1987 to implement the Indo-US Vaccine Action Programme (VAP).
   ValiRx PLC - Block Listing Application and Company Update - Vox Markets  2020/08/19 06:00:00 VOX Markets
Application has been made to the London Stock Exchange for the block listing of securities in respect of 9,034,732 ordinary shares of 0.1 pence each to be admitted to trading on AIM.. The block listing application relates to 9,034,732 ordinary shares of 0.1 pence each to be issued from time to time in order to satisfy the potential exercise of the Fundraise…
   ValiRx PLC - Holding(s) in Company - Vox Markets  2020/08/14 14:57:00 VOX Markets
RNS Number: 2357 W ValiRx PLC 14 August 2020 TR-1: S tandard form for notification of major holdings. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
   ValiRx PLC - Director/PDMR Shareholding - Vox Markets  2020/08/07 13:20:00 VOX Markets
London, UK 7 August 2020: ValiRx Plc, the clinical stage biotechnology company announces the following dealing in the ordinary shares of the Company made by a Director.. On 7 August 2020, the Company was informed that Dr Kevin Cox, Non-executive Chairman of the Company, acquired 117,000 ValiRx ordinary shares at an average price of 8.2 pence per share on 7 August…
   Valor Resources : Quarterly Cashflow Report.pdf (7) | MarketScreener  2020/08/03 07:44:29 MarketScreener
Rule 5.5 Appendix 5B Mining exploration entity or oil and gas exploration entity … | August 3, 2020
   India to play impt part in producing Covid vaccines  2020/07/30 16:22:13 Economic Times India
MUMBAI: India has a crucial role to play in the production of Covid-19 vaccines, with the largest manufacturing capacity in the world, top experts and researchers said on Thursday, while also emphasising that there should be no compromises on safety, efficacy and equitable distribution.“India’s private sector has an important role as the world’s leading manufacturer of vaccines. And as effective global vaccines emerge, India’s manufacturing capability is going to be very important,” said Anthony S Fauci, director of the National Institute of Allergy and Infectious Diseases, who oversees vaccine development in the US.Fauci was among the leading infectious disease experts and vaccine researchers who took part in the India Vaccine Symposium organised by the Indian Council of Medical Research. Adrian Hill, director of the Jenner Institute, based within the University of Oxford, which has one of the leading vaccine candidates for Covid-19, and Peter Piot, director of the London School of Hygiene & Tropical Medicine, were among the speakers.NIAID and India’s Department of Biotechnology tied up in 1987 to implement the Indo-US Vaccine Action Programme (VAP).
   Valor Resources : Quarterly Cashflow Report.pdf (7) | MarketScreener  2020/08/03 07:44:29 MarketScreener
Rule 5.5 Appendix 5B Mining exploration entity or oil and gas exploration entity … | August 3, 2020
   India to play impt part in producing Covid vaccines  2020/07/30 16:22:13 Economic Times India
MUMBAI: India has a crucial role to play in the production of Covid-19 vaccines, with the largest manufacturing capacity in the world, top experts and researchers said on Thursday, while also emphasising that there should be no compromises on safety, efficacy and equitable distribution.“India’s private sector has an important role as the world’s leading manufacturer of vaccines. And as effective global vaccines emerge, India’s manufacturing capability is going to be very important,” said Anthony S Fauci, director of the National Institute of Allergy and Infectious Diseases, who oversees vaccine development in the US.Fauci was among the leading infectious disease experts and vaccine researchers who took part in the India Vaccine Symposium organised by the Indian Council of Medical Research. Adrian Hill, director of the Jenner Institute, based within the University of Oxford, which has one of the leading vaccine candidates for Covid-19, and Peter Piot, director of the London School of Hygiene & Tropical Medicine, were among the speakers.NIAID and India’s Department of Biotechnology tied up in 1987 to implement the Indo-US Vaccine Action Programme (VAP).
   ValiRx PLC Broker Option - Fully Subscribed  2020/07/24 11:38:00 ADVFN UK
ValiRx PLC 24 July 2020 VALIRX PLC ("ValiRx", the "Company" or the "Group") Broker Option - Fully…
   ValiRx PLC Second Price Monitoring Extn  2020/07/23 15:41:00 ADVFN UK
ValiRx PLC 23 July 2020 Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this…
   ValiRx PLC Price Monitoring Extension  2020/07/23 15:36:00 ADVFN UK
ValiRx PLC 23 July 2020 Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction…

calendar